DOSSIER · 13F-HR · Q2 2026

TFG Asset Management GP Ltd

$635M in tracked AUM across 43 positions as of Q2 2026.

TA
CIK 0001515070 · last filed Jun 30, 2026
Total AUM
$635M
as of Q2 2026
Holdings
43
positions
Whale Score
68
68
tracked
Activity
no data
changes this Q
AI Analysis · Q2 2026
Comprehensive Analysis of TFG Asset Management GP Ltd 13F Filing (Q3 2025)
Portfolio Overview

TFG Asset Management GP Ltd manages a concentrated portfolio valued at approximately $670.17 million as of September 30, 2025. This represents a growth of 8.0% from the previous quarter's value of $620.75 million. The firm employs a high-conviction strategy characterized by significant concentration in top-tier names, with the top two holdings accounting for nearly 60% of the total ass...

Key Holdings

The portfolio is dominated by two "mega-positions" that define its performance profile:

  • UiPath Inc. (PATH) is the largest holding, comprising 33.84% of the portfolio ($226.79M). The firm increased this stake by 23.5% during the quarter, adding $51.15 million. This suggests a strong conviction in the company's AI and automation growth trajectory.
  • Alibaba Group (BABA) is the second-largest position at 26.09% ($174.85M). However, the firm reduced this stake by 5.0% (approx. $47.13M), potentially taking profits or rebalancing risk after a strong run, or adjusting exposure to the Chinese market.

Beyond the top two, the portfolio drops off significantly in position size. The third largest holding, Kolibri Global Energy, represents only 5.84% of the portfolio. Other notable positions include Lyft (3.28%) and Oatly Group (2.75%), alongside smaller stakes in biotech firms such as Autolus Therapeutics and Celdex Therapeutics.

Analysis generated by 13F Insight from SEC Form 13F filing data · Q2 2026. Methodology

Quarter at a glance — Q2 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q2 2026.

#HoldingValueSharesWeight
01
PATH
UIPATH INC
$336M30.9M53.0%
02
KGEI
KOLIBRI GLOBAL ENERGY INC
$34M6.8M5.3%
03
AUTL
AUTOLUS THERAPEUTICS LTD
$15M9.5M2.4%
04
LYFT
LYFT INC
$15M1.0M2.3%
05
DFTX
DEFINIUM THERAPEUTICS INC
$14M287K2.1%
06
WK
WORKIVA INC
$12M250K1.9%
07
SLN
SILENCE THERAPEUTICS PLC
$12M1.1M1.8%
08
CXM
SPRINKLR INC
$11M2.2M1.8%
09
MBX
MBX BIOSCIENCES INC
$11M204K1.8%
10
ALKT
ALKAMI TECHNOLOGY INC
$11M600K1.7%

Filing history

2026Q2Jun 30
$635M 23.3%
43 positionsView →
2026Q1Mar 31
$515M 8.6%
40 positionsView →
2025Q4Dec 31
$474M 29.2%
31 positionsView →
2025Q3Sep 30
$670M 8.0%
37 positionsView →
2025Q2Jun 30
$621M 109.4%
40 positionsLocked
2025Q1Mar 31
$296M 26.9%
23 positionsLocked
2024Q4Dec 31
$406M 14.4%
28 positionsLocked
2024Q3Sep 30
$355M 11.6%
26 positionsLocked
2024Q2Jun 30
$401M 9.2%
30 positionsLocked
2024Q1Mar 31
$441M 6.3%
32 positionsLocked
2023Q4Dec 31
$415M 24.3%
35 positionsLocked
2023Q3Sep 30
$548M 26.0%
50 positionsLocked
Showing 12 of 51